[Effects of interleukin 10 gene modified bone marrow mesenchymal stem cells on expression of inflammatory cytokines and neuronal apoptosis in rats after cerebral ischemia reperfusion injury]

Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi. 2017 Feb 15;31(2):240-245. doi: 10.7507/1002-1892.201605095.
[Article in Chinese]

Abstract

Objective: To explore the effects of interleukin 10 (IL-10) gene modified bone marrow mesenchymal stem cells (BMSCs) on the expression of inflammatory cytokines and neuronal apoptosis in rats after cerebral ischemia reperfusion injury.

Methods: BMSCs were cultured by whole bone marrow adherence screening method. The properties of BMSCs were identified by immunocytochemical methods. BMSCs at passage 3 were transfected with recombinant adenovirus IL-10 gene (AdIL-10-BMSCs). The model of middle cerebral artery occlusion was made in 40 adult male Sprague Dawley rats by thread embolism method. The rats were randomly divided into 4 groups ( n=10). At 3 hours after modelling, the rats of groups A, B, C, and D received tail intravenous injection of 1 mL L-DMEM medium containing 10% FBS, 61.78 ng IL-10, 1 mL BMSCs suspension (2×10 6 cells/mL), and 1 mL AdIL-10-BMSCs cell suspension (2×10 6 cells/mL), respectively. The cells were labelled with BrdU before cell transplantation in groups C and D. At 7 days after reperfusion, the brain tissue was harvested to detect the expression of OX42 by immunohistochemical assay, to determine the concentration of tumor necrosis factor α (TNF-α) and IL-1β by ELISA, and to detect the apoptosis by TUNEL assay. BrdU labelled cells were observed by immunofluorescence staining in groups C and D.

Results: BrdU labelled positive cells with green fluorescence were observed in the brain tissue of groups C and D, which mainly distributed in the striatum, cerebral cortex, and subcortex around the infarction area. The number of OX42 positive cells was significantly less in groups B, C, and D than group A ( P<0.05), and in group D than groups B and C ( P<0.05). Compared with the other 3 groups, the contents of TNF-α and IL-1β significantly decreased in group D ( P<0.05). TUNEL assay showed that the apoptotic cells (TUNEL positive cells) were mainly seen in the striatum and fronto parietal subcortical tissues (equivalent to ischemic penumbra). The number of TUNEL positive cells in group D was significantly less than that in groups A, B, and C ( P<0.05).

Conclusion: AdIL-10-BMSCs can inhibit secretion of TNF-α and IL-1β from microglial cells and inhibit the nerve cell apoptosis around infarct brain tissue, which might contribute to its protective role upon cerebral ischemia reperfusion injury.

目的: 探讨 IL-10 基因修饰的 BMSCs 对大鼠脑缺血再灌注损伤(ischemia reperfusion injury,IRI)炎性因子及神经细胞凋亡的影响。.

方法: 取 SD 大鼠骨髓,采用贴壁培养法分离培养 BMSCs,经免疫组织化学染色鉴定后,取第 3 代 BMSCs 以重组腺病毒(recombinant adenovirus,Ad)介导 IL-10 基因转染(AdIL-10-BMSCs)。取 40 只清洁级成年 SD 雄性大鼠,采用线栓法制备大脑中动脉阻塞模型后随机分为 4 组,每组 10 只。模型制备后 3 h 于各组大鼠尾静脉注射 1 mL 含 10%FBS 的 L-DMEM 培养液(A 组)、61.78 ng IL-10(B 组)、1 mL BMSCs 悬液(细胞浓度为 2×10 6 个/mL,C 组)、1 mL AdIL-10-BMSCs 悬液(细胞浓度 2×10 6 个/mL,D 组)。C、D 组细胞移植前采用 BrdU 标记。7 d 后大鼠经颈总动脉灌注处死取脑组织,免疫染色法检测小胶质细胞(OX42)表达,ELISA 法测定 TNF-α、IL-1β含量,TUNEL 法检测神经细胞凋亡;取 C、D 组组织行 BrdU 免疫荧光染色观察。.

结果: C、D 组脑组织中均见呈绿色荧光的 Brdu 阳性细胞,主要分布于梗死区周围的纹状体、大脑皮质、皮质下等。免疫组织化学染色示,B、C、D 组 OX42 阳性细胞数明显少于 A 组,D 组少于 B、C 组,比较差异有统计学意义( P<0.05)。ELISA 检测示 D 组大鼠脑组织中 TNF-α、IL-1β含量较其余 3 组明显降低( P<0.05)。TUNEL 法检测各组凋亡细胞(TUNEL 阳性细胞)主要见于梗死灶周围的纹状体及额顶皮质下脑组织(相当于缺血半暗带),D 组与 A、B、C 组比较差异有统计学意义( P<0.05)。.

结论: AdIL-10-BMSCs 能通过抑制小胶质细胞分泌促炎性因子 TNF-α、IL-1β,抑制梗死灶周围脑组织神经细胞凋亡,对大鼠脑 IRI 起保护作用。.

Keywords: Bone marrow mesenchymal stem cells; apoptosis; interleukin 10; interleukin 1β; middle cerebral artery occlusion; rats; tumor necrosis factor α.

MeSH terms

  • Animals
  • Apoptosis*
  • Bone Marrow Cells
  • Cytokines / metabolism*
  • Interleukin-10 / physiology*
  • Male
  • Mesenchymal Stem Cell Transplantation
  • Mesenchymal Stem Cells*
  • Random Allocation
  • Rats
  • Rats, Sprague-Dawley
  • Reperfusion Injury*
  • Tumor Necrosis Factor-alpha

Substances

  • Cytokines
  • Tumor Necrosis Factor-alpha
  • Interleukin-10

Grants and funding

山东省医药卫生科技发展计划项目(2013WS0289)